Prognostic relevance of persistent haematuria in patients with lupus nephritis
Clinical Kidney Journal · 02.01.2026 · 19 (1)
DOI: 10.1093/ckj/sfaf348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 13.11.2025. Verfasst von Xuan Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Hunan Province of China, Youth Science Foundation of Henan Province.
Abstract (Originalsprache)
Background
This study aimed to investigate the significance of persistent haematuria in lupus nephritis (LN).
Methods
A total of 178 patients with LN were enrolled and regularly followed up from December 2016 to September 2022. Follow-up duration was from LN diagnosis to the patient’s latest visit or terminated at the onset of endpoint events if they occurred. Their clinical and laboratory data as well as outcomes were monitored and analysed from the enrolment point until the final visit.
Results
A total of 138 of 178 (77.5%) patients with LN presented with haematuria at the initial diagnosis. During follow-up, 34 patients (19.1%) had no haematuria, 72 (40.4%) patients initially diagnosed but later resolved and 66 (37.1%) exhibited persistent haematuria. Furthermore, patients with persistent haematuria showed higher Systemic Lupus Erythematosus Disease Activity Index scores (12.3 ± 2.9 versus 10.7 ± 3.6; P = .002), lower haemoglobin (92.7 ± 25.4 g/l versus 102.0 ± 21.1; P = .010), albumin (24.9 ± 6.8 g/l versus 27.5 ± 7.6; P = .024) and decreased C3 {median 0.4 g/l [interquartile range (IQR) 0.3–0.5]} versus 0.5 [0.3–0.6]; P = .009} and C4 [median 0.1 g/l (IQR 0.0–0.1) versus 0.1 (0–0.1); P = .012] and elevated blood urea nitrogen and serum creatinine [median 8.9 mmol/l (IQR 6.7–14.8) versus 5.7 (4.4–8.8) and median 90.0 μmol/l (IQR 64.5–132.3) versus 62.0 (48.0–80.0); all P < .001, respectively] compared with those without persistent haematuria (n = 106). In time-dependent Cox proportional hazards regression models, persistent haematuria exhibited a significant overall time-averaged effect on composite clinical endpoints, with an adjusted hazard ratio of 3.40 (95% CI 1.06–10.90; P = .039). Notably, this risk effect was not fixed but showed an increasing trend over time—at 1 months of follow-up, the risk of adverse outcomes in patients with persistent haematuria had increased to 10.37-fold.
Conclusions
Almost 37.1% of patients exhibited persistent haematuria in LN. Furthermore, persistent haematuria independently predicted adverse outcomes, with significantly higher risks for all-cause mortality and progression to renal replacement therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, China.
- Henan Provincial Key Laboratory of Kidney Disease and Immunology, Zhengzhou, China.
ORCID-Profile: Lin-Lin Li
Förderung
- Key Research and Development Program of Hunan Province of China
- Youth Science Foundation of Henan Province
Zitieren
APA
Chen, X., Li, L. L., Li, N., Wang, P., & Cao, H. X. (2026). Prognostic relevance of persistent haematuria in patients with lupus nephritis. Clinical Kidney Journal, 19(1). https://doi.org/10.1093/ckj/sfaf348
Vancouver
Chen X, Li LL, Li N, Wang P, Cao HX. Prognostic relevance of persistent haematuria in patients with lupus nephritis. Clinical Kidney Journal. 2026;19(1). doi:10.1093/ckj/sfaf348
BibTeX
@article{Chen2026,
author = {Chen, Xuan and Li, Lin-Lin and Li, Na and Wang, Pei and Cao, Hui-Xia},
title = {Prognostic relevance of persistent haematuria in patients with lupus nephritis},
journal = {Clinical Kidney Journal},
year = {2026},
volume = {19},
number = {1},
doi = {10.1093/ckj/sfaf348}
}
EUVIMED